- Bevorzugter Name
- (7R,9R,10S,12S,18R,20R,21R,23S)-12,16,23,30-tetrahydroxy-7,9,18,20-tetramethyl-8,11,19,22-tetraoxanonacyclo[15.11.1.16,26.02,15.03,12.04,27.05,10.021,29.023,28]triaconta-1(28),2,4(27),5,15,17(29),26(30)-heptaene-14,25-dione
- IUPAC
- (7R,9R,10S,12S,18R,20R,21R,23S)-12,16,23,30-tetrahydroxy-7,9,18,20-tetramethyl-8,11,19,22-tetraoxanonacyclo[15.11.1.16,26.02,15.03,12.04,27.05,10.021,29.023,28]triaconta-1(28),2,4(27),5,15,17(29),26(30)-heptaene-14,25-dione
- Englischer Name
- Xanthoaphin sl-2
- Summenformel
- C30H26O10
- Molmasse
- 546.52
Namen und Synonyme
Xanthoaphin sl-26H,13H-2,4,9,11-Tetraoxadibenzo[bc,kl]coronene-6,13-dione, 1,3,3a,4a,5,8,10,10a,11a,12-decahydro-4a,7,11a,14-tetrahydroxy-1,3,8,10-tetramethyl-, (1R,3R,3aR,4aS,8R,10R,10aS,11aS)-rel- (9CI)
Datenbank-Bezeichner
- PubChem CID
- 101821071
- Nikkaji
- J238.353E